336 filings
8-K
NNVC
NanoViricides Inc
10 Dec 20
Submission of Matters to a Vote of Security Holders
4:30pm
424B5
NNVC
NanoViricides Inc
3 Dec 20
Prospectus supplement for primary offering
4:30pm
8-K
NNVC
NanoViricides Inc
19 Nov 20
NanoViricides Strengthens its Board of Directors with Addition of Industry Veteran Brian Zucker, CPA
4:53pm
10-Q
2020 Q1
NNVC
NanoViricides Inc
Quarterly report
16 Nov 20
4:31pm
DEF 14A
NNVC
NanoViricides Inc
Definitive proxy
26 Oct 20
4:25pm
NT 10-K
4tw lnl9e1
28 Sep 20
Notice of late annual filing
4:30pm
8-K
wluv 8i1avnin
4 Sep 20
NanoViricides is Developing Drugs Against SARS-CoV-2 with an Integrated Approach to Combat COVID-19, as Reported at The LD 500 Virtual Conference
4:05pm
8-K
abmq273we8ydjj
3 Aug 20
Entry into a Material Definitive Agreement
5:19pm
424B5
rf9fr3nvtdij
31 Jul 20
Prospectus supplement for primary offering
5:29pm
SC 13G
t9sq66kdyniviml9
20 Jul 20
NANOVIRICIDES / Altium Capital Management ownership change
3:29pm
8-K
z5k6x3z8edw2iibh1pit
13 Jul 20
Nanoviricides Closes on $11.5 Million Underwritten Public Offering of Common Stock
4:52pm
424B5
lh4h8tqshvt3db w6
9 Jul 20
Prospectus supplement for primary offering
5:13pm
424B5
wtn 0m0ov2sn519hv
8 Jul 20
Prospectus supplement for primary offering
9:57pm
8-K
52bc5w z6mci2wvy2m
4 Jun 20
Departure of Directors or Certain Officers
4:49pm
SC 13G
m75ti5uy3hwdguvmoryn
29 May 20
NANOVIRICIDES / CVI Investments ownership change
10:42am
8-K
b9ffjz3
22 May 20
NanoViricides Announces Pricing of $10.2 Million Registered Direct Offering
4:10pm
424B5
emk8t64a4sf
21 May 20
Prospectus supplement for primary offering
9:21pm
8-K
97sz t5c0ka
19 May 20
Departure of Directors or Certain Officers
5:15pm